Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse

Eur Urol Oncol. 2022 Dec;5(6):732-733. doi: 10.1016/j.euo.2022.01.005. Epub 2022 Feb 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Goals
  • Humans
  • Male
  • Neoplasm Recurrence, Local / therapy
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms* / therapy
  • Salvage Therapy / adverse effects

Substances

  • Prostate-Specific Antigen